2:30 p.m. 6. Compounding: Background and USP’s Role (15 min each)
a. Regulatory Perspective TBD
b. AVMA Perspective Butch KuKanich
c. Industry Perspective Rob Hunter
d. USP Perspective Gigi Davidson
e. Discussion
Source found here
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Monday, November 5, 2012
Veterinary Drugs Stakeholder Forum Meeting #1 for 2010-2015 Friday, November 9, 2012 USP Headquarters, Rockville, Maryland Sanja Modric, DVM, Ph.D., FDA Center for Veterinary Medicine (CVM), Chair Draft Agenda
2:30 p.m. 6. Compounding: Background and USP’s Role (15 min each)
a. Regulatory Perspective TBD
b. AVMA Perspective Butch KuKanich
c. Industry Perspective Rob Hunter
d. USP Perspective Gigi Davidson
e. Discussion
Source found here
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment